Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.37 |
| ▸ | GABRE | P78334 | 2/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.37 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.37 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.37 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | KDM6B | O15054 | 1/20 | 0.37 |
| ▸ | KDM5C | P41229 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetoacetic Acid SCHEMBL8843224 | 1.00 | ALDH1A1 (0.38) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetoacetic Acid SCHEMBL28466057 | 0.98 | ALDH1A1 (0.36) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetoacetic Acid SCHEMBL8751686 | 0.89 | ALDH1A1 (0.41) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetoacetic Acid SCHEMBL1638934 | 0.84 | TDP1 (0.46) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| Acetoacetic Acid SCHEMBL1640437 | 0.84 | TDP1 (0.46) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| Acetoacetic Acid SCHEMBL18154854 | 0.84 | ALDH1A1 (0.43) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetoacetic Acid SCHEMBL1058961 | 0.84 | TDP1 (0.50) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| Acetoacetic Acid SCHEMBL28640192 | 0.84 | TDP1 (0.50) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| Acetoacetic Acid SCHEMBL5797078 | 0.84 | TDP1 (0.50) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| 1,3-Butanediol SCHEMBL2195943 | 0.84 | TDP1 (0.40) | ALDH1A1GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | AARHUS UNIVERSITET (DK) | 2025-10-02 | — | — | US | claimed |
| US-20230399288-A1 | LACTATE/KETONE BODY ESTERS | AARHUS UNIVERSITET (DK) | 2023-12-14 | — | — | US | claimed |
| US-20230285348-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2023-09-14 | — | — | US | claimed |
| EP-4240345-A1 | LACTATE/KETONE BODY ESTERS | Aarhus Universitet (DK) | 2023-09-13 | — | — | EP | claimed |
| CN-116528848-A | Lactic acid/ketone body esters | 奥胡斯大学 | 2023-08-01 | — | — | CN | claimed |
| US-11596616-B2 | Compositions and methods for weight loss maintenance | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-03-07 | — | — | US | claimed |
| WO-2022096637-A1 | LACTATE/KETONE BODY ESTERS | AARHUS UNIVERSITET (DK) | 2022-05-12 | — | — | WO | claimed |
| US-20200397736-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2020-12-24 | — | — | US | claimed |
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | AARHUS UNIVERSITET (DK) | 2025-10-02 | — | — | US | disclosed |
| EP-4595775-A2 | BHB-CITRATE COMBINATION PRODUCTS FOR RENAL HEALTH AND TREATING DISEASE | The Regents of the University of California (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4519239-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | Aarhus Universitet (DK) | 2025-03-12 | — | — | EP | disclosed |
| US-20240157322-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2024-05-16 | — | — | US | disclosed |
| US-20240149237-A1 | ACETOACETYL POLYMER - BASED MICROCAPSULES | FIRMENICH SA (CH) | 2024-05-09 | — | — | US | disclosed |
| EP-4313393-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | Firmenich SA (CH) | 2024-02-07 | — | — | EP | disclosed |
| EP-1009377-A1 | MEDICAL USES OF PYRUVATES | Case Western Reserve University (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1998051277-A1 | MEDICAL USES OF PYRUVATES | CASE WESTERN RESERVE UNIVERSITY (US) | 1998-11-19 | — | — | WO | disclosed |
| EP-0599478-B1 | Coating composition | ROHM & HAAS (US) | 1997-04-16 | — | — | EP | disclosed |
| US-5426129-A | Curable | ROHM AND HAAS COMPANY (US) | 1995-06-20 | — | — | US | disclosed |
| US-5349026-A | To form a tough film from aqueous dispersion of vinyl or arylic polymer | ROHM AND HAAS COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| EP-0599478-A1 | Coating composition | ROHM AND HAAS COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399288-A1 | LACTATE/KETONE BODY ESTERS | LDHB, LDHA, IL1B | ALDH1A1 314/4885GABRP 1749/4885GABRD 3640/4885 |
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | LDHB, LDHA, LCT | ALDH1A1 591/4885GABRP 1961/4885GABRD 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.